Rigel Pharmaceuticals Files 8-K
Ticker: RIGL · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1034842
| Field | Detail |
|---|---|
| Company | Rigel Pharmaceuticals Inc (RIGL) |
| Form Type | 8-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, routine-update
Related Tickers: RIGL
TL;DR
Rigel Pharma filed an 8-K on 3/27/25, mostly for routine updates and exhibits.
AI Summary
On March 27, 2025, Rigel Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events or transactions detailed in the provided text.
Why It Matters
This 8-K filing indicates Rigel Pharmaceuticals is providing updates or submitting required financial documentation to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any immediate material adverse events.
Key Players & Entities
- RIGEL PHARMACEUTICALS, INC. (company) — Registrant
- March 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 611 Gateway Boulevard Suite 900 (address) — Principal executive offices
- South San Francisco, CA (location) — City and State of principal executive offices
- 94080 (zip_code) — Zip code of principal executive offices
- ( 650 ) 624-1100 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Rigel Pharmaceuticals?
The filing is for 'Other Events' and 'Financial Statements and Exhibits', indicating routine updates or submissions to the SEC.
On what date was this 8-K report filed or effective?
The earliest event reported is March 27, 2025.
Where is Rigel Pharmaceuticals, Inc. incorporated?
Rigel Pharmaceuticals, Inc. is incorporated in Delaware.
What is the principal executive office address for Rigel Pharmaceuticals?
The principal executive offices are located at 611 Gateway Boulevard, Suite 900, South San Francisco, CA 94080.
What is the registrant's telephone number?
The registrant's telephone number is (650) 624-1100.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding RIGEL PHARMACEUTICALS INC (RIGL).